1.Feng WW, Wilkins O, et al. CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies. Cell Reports, 29(11):3405-3420 (2019).
2.Wang H, Franco F, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nature Immunology, 21(3):298-308 (2020).
3.Tanase C, Enciu AM, et al. Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately? International Journal of Molecular Sciences, 23(2):604 (2022).